NASDAQ:SCPHScpharmaceuticals Stock Price, Forecast & News

Scpharmaceuticals' stock was trading at $7.77 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, SCPH shares have decreased by 8.2% and is now trading at $7.13. View which stocks have been most impacted by Coronavirus.

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Scpharmaceuticals in the last year. There are currently 2 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Scpharmaceuticals.

Scpharmaceuticals is scheduled to release its next quarterly earnings announcement on Wednesday, August 5th 2020. View our earnings forecast for Scpharmaceuticals.

Scpharmaceuticals Inc (NASDAQ:SCPH) announced its earnings results on Tuesday, May, 12th. The company reported ($0.35) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.54) by $0.19. View Scpharmaceuticals' earnings history.

3 Wall Street analysts have issued twelve-month price objectives for Scpharmaceuticals' stock. Their forecasts range from $10.00 to $15.00. On average, they expect Scpharmaceuticals' stock price to reach $13.00 in the next year. This suggests a possible upside of 82.3% from the stock's current price. View analysts' price targets for Scpharmaceuticals.

News headlines about SCPH stock have been trending negative on Tuesday, InfoTrie Sentiment reports. The research group scores the sentiment of press coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Scpharmaceuticals earned a daily sentiment score of -2.1 on InfoTrie's scale. They also assigned media headlines about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the company's share price in the immediate future. View the latest news about Scpharmaceuticals.

Scpharmaceuticals saw a increase in short interest during the month of June. As of June 30th, there was short interest totaling 58,300 shares, an increase of 81.6% from the June 15th total of 32,100 shares. Based on an average daily trading volume, of 110,200 shares, the short-interest ratio is currently 0.5 days. Currently, 0.3% of the shares of the company are short sold. View Scpharmaceuticals' Current Options Chain.

Some companies that are related to Scpharmaceuticals include Collegium Pharmaceutical (COLL), NextCure (NXTC), Corbus Pharmaceuticals (CRBP), Kala Pharmaceuticals (KALA), Crinetics Pharmaceuticals (CRNX), Syros Pharmaceuticals (SYRS), Basilea Pharmaceutica (BPMUF), Neoleukin Therapeutics (NLTX), Legend Biotech (CALT), Urogen Pharma (URGN), Athersys (ATHX), Syndax Pharmaceuticals (SNDX), Mirum Pharmaceuticals (MIRM), Flexion Therapeutics (FLXN) and Catalyst Pharmaceuticals (CPRX). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Scpharmaceuticals investors own include Adamas Pharmaceuticals (ADMS), Selecta Biosciences (SELB), Crispr Therapeutics (CRSP), Protalix Biotherapeutics (PLX), TG Therapeutics (TGTX), Clearside Biomedical (CLSD), Exelixis (EXEL), Fate Therapeutics (FATE), ImmunoGen (IMGN) and Melinta Therapeutics (MLNT).

(SCPH) raised $96 million in an initial public offering on Friday, November 17th 2017. The company issued 6,400,000 shares at $14.00-$16.00 per share. Jefferies, Leerink Partners and BMO Capital Markets served as the underwriters for the IPO.

Scpharmaceuticals trades on the NASDAQ under the ticker symbol "SCPH."

Shares of SCPH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of SCPH stock can currently be purchased for approximately $7.13.

Scpharmaceuticals has a market capitalization of $149.80 million. The company earns $-33,000,000.00 in net income (profit) each year or ($1.77) on an earnings per share basis. Scpharmaceuticals employs 21 workers across the globe.

The official website for Scpharmaceuticals is www.scpharma.com.

Scpharmaceuticals' mailing address is 2400 DISTRICT AVENUE SUITE 310, BURLINGTON MA, 01830. The company can be reached via phone at 617-517-0730 or via email at [email protected]